Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer

por Li, Ziqi, Aboian, Mariam S., Zhu, Xiaohua, Marquez-Nostra, Bernadette
Publicado 2022

Targeting HER2 in Nuclear Medicine for Imaging and Therapy

por Massicano, Adriana V. F., Marquez-Nostra, Bernadette V., Lapi, Suzanne E.
Publicado 2018

Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer

por Fang, Hanyi, Cavaliere, Alessandra, Li, Ziqi, Huang, Yiyun, Marquez-Nostra, Bernadette
Publicado 2021

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma

por Su, David, Djureinovic, Dijana, Schoenfeld, David, Marquez-Nostra, Bernadette, Olino, Kelly, Jilaveanu, Lucia, Kluger, Harriet
Publicado 2023

PET Imaging in Animal Models of Alzheimer’s Disease

por Chen, Baosheng, Marquez-Nostra, Bernadette, Belitzky, Erika, Toyonaga, Takuya, Tong, Jie, Huang, Yiyun, Cai, Zhengxin
Publicado 2022

ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer

por Li, Ziqi, Belitzky, Erika, Blaha, Ondrej, Cavaliere, Alessandra, Katz, Samantha R., Aboian, Mariam, Melegari, Lindy, Rajabimoghadam, Khashayar, Kurpiewski, Stephen, Zhu, Xiaohua, Marquez-Nostra, Bernadette
Publicado 2023

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent

por Marquez-Nostra, Bernadette V., Lee, Supum, Laforest, Richard, Vitale, Laura, Nie, Xingyu, Hyrc, Krzysztof, Keler, Tibor, Hawthorne, Thomas, Hoog, Jeremy, Li, Shunqiang, Dehdashti, Farrokh, Ma, Cynthia X., Lapi, Suzanne E.
Publicado 2017